-
1
-
-
0033952103
-
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
-
Baba T.W., Liska V., Hofmann-Lehmann R. et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000; 6:200-206.
-
(2000)
Nat Med
, vol.6
, pp. 200-206
-
-
Baba, T.W.1
Liska, V.2
Hofmann-Lehmann, R.3
-
2
-
-
0033951746
-
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
-
Mascola J.R., Stiegler G., VanCott T.C. et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000; 6:207-210.
-
(2000)
Nat Med
, vol.6
, pp. 207-210
-
-
Mascola, J.R.1
Stiegler, G.2
VanCott, T.C.3
-
3
-
-
0034864776
-
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/ human immunodeficiency virus at serum levels giving complete neutralization in vitro
-
Parren P.W., Marx P.A., Hessell A.J. et al. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/ human immunodeficiency virus at serum levels giving complete neutralization in vitro. J Virol 2001; 75:8340-8347.
-
(2001)
J Virol
, vol.75
, pp. 8340-8347
-
-
Parren, P.W.1
Marx, P.A.2
Hessell, A.J.3
-
4
-
-
0036786482
-
Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection
-
Allen T.M., Jing P., Calore B. et al. Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection. J Virol 2002; 76:10507-10511.
-
(2002)
J Virol
, vol.76
, pp. 10507-10511
-
-
Allen, T.M.1
Jing, P.2
Calore, B.3
-
5
-
-
0036194524
-
Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication
-
Allen T.M., Mortara L., Mothe B.R. et al. Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication. J Virol 2002; 76:4108-4112.
-
(2002)
J Virol
, vol.76
, pp. 4108-4112
-
-
Allen, T.M.1
Mortara, L.2
Mothe, B.R.3
-
6
-
-
10744225749
-
Multispecific vaccineinduced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239
-
Vogel T.U., Reynolds M.R., Fuller D.H. et al. Multispecific vaccineinduced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J Virol 2003; 77:13348-13360.
-
(2003)
J Virol
, vol.77
, pp. 13348-13360
-
-
Vogel, T.U.1
Reynolds, M.R.2
Fuller, D.H.3
-
7
-
-
0035668020
-
Non-human primates: Essential partners in biomedical research
-
Bontrop R.E. Non-human primates: essential partners in biomedical research. Immunol Rev 2001; 183:5-9.
-
(2001)
Immunol Rev
, vol.183
, pp. 5-9
-
-
Bontrop, R.E.1
-
8
-
-
1842328057
-
Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry
-
Kirchhoff F., Pohlmann S., Hamacher M. et al. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J Virol 1997; 71:6509-6516.
-
(1997)
J Virol
, vol.71
, pp. 6509-6516
-
-
Kirchhoff, F.1
Pohlmann, S.2
Hamacher, M.3
-
9
-
-
0030892146
-
Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry
-
Chen Z., Zhou P., Ho D.D., Landau N.R., and Marx P.A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997; 71:2705-2714.
-
(1997)
J Virol
, vol.71
, pp. 2705-2714
-
-
Chen, Z.1
Zhou, P.2
Ho, D.D.3
Landau, N.R.4
Marx, P.A.5
-
10
-
-
0032551184
-
Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: A comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac
-
Chen Z., Gettie A., Ho D.D., and Marx P.A. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology 1998; 246:113-124.
-
(1998)
Virology
, vol.246
, pp. 113-124
-
-
Chen, Z.1
Gettie, A.2
Ho, D.D.3
Marx, P.A.4
-
11
-
-
17844374605
-
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
-
Mattapallil J.J., Douek D.C., Hill B. et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-1097.
-
(2005)
Nature
, vol.434
, pp. 1093-1097
-
-
Mattapallil, J.J.1
Douek, D.C.2
Hill, B.3
-
12
-
-
17844376742
-
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells
-
Li Q., Duan L., Estes J.D. et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005; 434:1148-1152.
-
(2005)
Nature
, vol.434
, pp. 1148-1152
-
-
Li, Q.1
Duan, L.2
Estes, J.D.3
-
13
-
-
29244455769
-
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag
-
Casimiro D.R., Wang F., Schleif W.A. et al. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J Virol 2005; 79:15547-15555.
-
(2005)
J Virol
, vol.79
, pp. 15547-15555
-
-
Casimiro, D.R.1
Wang, F.2
Schleif, W.A.3
-
14
-
-
68949110126
-
Vaccine-induced, Simian Immunodeficiency Virus-specific CD8+ T cells reduce virus replication but do not protect from Simian Immunodeficiency Virus disease progression
-
Engram J.C., Dunham R.M., Makedonas G. et al. Vaccine-induced, Simian Immunodeficiency Virus-specific CD8+ T cells reduce virus replication but do not protect from Simian Immunodeficiency Virus disease progression. J Immunol 2009; 183:706-717.
-
(2009)
J Immunol
, vol.183
, pp. 706-717
-
-
Engram, J.C.1
Dunham, R.M.2
Makedonas, G.3
-
15
-
-
17144465337
-
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239
-
Horton H., Vogel T.U., Carter D.K. et al. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. J Virol 2002; 76:7187-7202.
-
(2002)
J Virol
, vol.76
, pp. 7187-7202
-
-
Horton, H.1
Vogel, T.U.2
Carter, D.K.3
-
16
-
-
29744438821
-
Cytotoxic Tlymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques
-
McDermott A.B., O'Connor D.H., Fuenger S. et al. Cytotoxic Tlymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques. J Virol 2005; 79:15556-15566.
-
(2005)
J Virol
, vol.79
, pp. 15556-15566
-
-
McDermott, A.B.1
O'Connor, D.H.2
Fuenger, S.3
-
17
-
-
52649177196
-
Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency
-
Vaccari M., Mattapallil J., Song K. et al. Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. J Virol 2008; 82:9629-9638.
-
(2008)
J Virol
, vol.82
, pp. 9629-9638
-
-
Vaccari, M.1
Mattapallil, J.2
Song, K.3
-
18
-
-
69449108369
-
-
Barouch D.H., Liu J., Lynch D.M. et al. Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine Against SIV Challenge in Rhesus Monkeys. J Virol 2009;
-
Barouch D.H., Liu J., Lynch D.M. et al. Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine Against SIV Challenge in Rhesus Monkeys. J Virol 2009;
-
-
-
-
19
-
-
55249117992
-
Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge
-
Demberg T., Boyer J.D., Malkevich N. et al. Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge. J Virol 2008; 82:10911-10921.
-
(2008)
J Virol
, vol.82
, pp. 10911-10921
-
-
Demberg, T.1
Boyer, J.D.2
Malkevich, N.3
-
20
-
-
62749156822
-
Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate
-
Yeh W.W., Jaru-Ampornpan P., Nevidomskyte D. et al. Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate. J Virol 2009; 83:2686-2696.
-
(2009)
J Virol
, vol.83
, pp. 2686-2696
-
-
Yeh, W.W.1
Jaru-Ampornpan, P.2
Nevidomskyte, D.3
-
21
-
-
13844294303
-
Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques
-
Abdel-Motal U.M., Gillis J., Manson K. et al. Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. Virology 2005; 333:226-238.
-
(2005)
Virology
, vol.333
, pp. 226-238
-
-
Abdel-Motal, U.M.1
Gillis, J.2
Manson, K.3
-
22
-
-
34249808840
-
Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS
-
Brown C.R., Czapiga M., Kabat J. et al. Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS. J Virol 2007; 81:5594-5606.
-
(2007)
J Virol
, vol.81
, pp. 5594-5606
-
-
Brown, C.R.1
Czapiga, M.2
Kabat, J.3
-
23
-
-
33744902339
-
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
-
Wilson N.A., Reed J., Napoe G.S. et al. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol 2006; 80:5875-5885.
-
(2006)
J Virol
, vol.80
, pp. 5875-5885
-
-
Wilson, N.A.1
Reed, J.2
Napoe, G.S.3
-
24
-
-
58149267963
-
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
-
Liu J., O'Brien K.L., Lynch D.M. et al. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009; 457:87-91.
-
(2009)
Nature
, vol.457
, pp. 87-91
-
-
Liu, J.1
O'Brien, K.L.2
Lynch, D.M.3
-
25
-
-
61949216736
-
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
-
Hansen S.G., Vieville C., Whizin N. et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 2009; 15:293-299.
-
(2009)
Nat Med
, vol.15
, pp. 293-299
-
-
Hansen, S.G.1
Vieville, C.2
Whizin, N.3
-
26
-
-
67449101823
-
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge
-
Wilson N.A., Keele B.F., Reed J.S. et al. Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. J Virol 2009; 83:6508-6521.
-
(2009)
J Virol
, vol.83
, pp. 6508-6521
-
-
Wilson, N.A.1
Keele, B.F.2
Reed, J.S.3
-
27
-
-
34547737913
-
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
-
Loffredo J.T., Maxwell J., Qi Y. et al. Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol 2007; 81:8827-8832.
-
(2007)
J Virol
, vol.81
, pp. 8827-8832
-
-
Loffredo, J.T.1
Maxwell, J.2
Qi, Y.3
-
28
-
-
43949088824
-
Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive Simian immunodeficiency virus-infected rhesus macaques
-
Maness N.J., Yant L.J., Chung C. et al. Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive Simian immunodeficiency virus-infected rhesus macaques. J Virol 2008; 82:5245-5254.
-
(2008)
J Virol
, vol.82
, pp. 5245-5254
-
-
Maness, N.J.1
Yant, L.J.2
Chung, C.3
-
29
-
-
33646461679
-
The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication
-
Yant L.J., Friedrich T.C., Johnson R.C. et al. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 2006; 80:5074-5077.
-
(2006)
J Virol
, vol.80
, pp. 5074-5077
-
-
Yant, L.J.1
Friedrich, T.C.2
Johnson, R.C.3
-
30
-
-
6344234923
-
Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition
-
Loffredo J.T., Sidney J., Wojewoda C. et al. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J Immunol 2004; 173:5064-5076.
-
(2004)
J Immunol
, vol.173
, pp. 5064-5076
-
-
Loffredo, J.T.1
Sidney, J.2
Wojewoda, C.3
-
31
-
-
0037189323
-
Diversity considerations in HIV-1 vaccine selection
-
Gaschen B., Taylor J., Yusim K. et al. Diversity considerations in HIV-1 vaccine selection. Science 2002; 296:2354-2360.
-
(2002)
Science
, vol.296
, pp. 2354-2360
-
-
Gaschen, B.1
Taylor, J.2
Yusim, K.3
-
32
-
-
56649105122
-
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebo-controlled, test-of-concept trial
-
Buchbinder S.P., Mehrotra D.V., Duerr A. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372:1881-1893.
-
(2008)
Lancet
, vol.372
, pp. 1881-1893
-
-
Buchbinder, S.P.1
Mehrotra, D.V.2
Duerr, A.3
-
33
-
-
56649114351
-
HIV-1 vaccineinduced immunity in the test-of-concept Step Study: A casecohort analysis
-
McElrath M.J., De Rosa S.C., Moodie Z. et al. HIV-1 vaccineinduced immunity in the test-of-concept Step Study: a casecohort analysis. Lancet 2008; 372:1894-1905.
-
(2008)
Lancet
, vol.372
, pp. 1894-1905
-
-
McElrath, M.J.1
De Rosa, S.C.2
Moodie, Z.3
-
34
-
-
58149143041
-
-
Reynolds M.R., We i l e r A.M., Weisgrau K.L. et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J Exp Med 2008; 205:2537-2550.
-
Reynolds M.R., We i l e r A.M., Weisgrau K.L. et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J Exp Med 2008; 205:2537-2550.
-
-
-
-
35
-
-
67649172577
-
Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity
-
Loffredo J.T., Sidney J., Bean A.T. et al. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol 2009; 182:7763-7775.
-
(2009)
J Immunol
, vol.182
, pp. 7763-7775
-
-
Loffredo, J.T.1
Sidney, J.2
Bean, A.T.3
-
36
-
-
0038581912
-
The influence of HLA genotype on AIDS
-
Carrington M., and O'Brien S.J. The influence of HLA genotype on AIDS. Annu Rev Med 2003; 54:535-551.
-
(2003)
Annu Rev Med
, vol.54
, pp. 535-551
-
-
Carrington, M.1
O'Brien, S.J.2
-
37
-
-
28644451011
-
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis
-
Gao X., Bashirova A., Iversen A.K. et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005; 11:1290-1292.
-
(2005)
Nat Med
, vol.11
, pp. 1290-1292
-
-
Gao, X.1
Bashirova, A.2
Iversen, A.K.3
-
38
-
-
33750869972
-
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1
-
Altfeld M., Kalife E.T., Qi Y. et al. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med 2006; 3:e403.
-
(2006)
PLoS Med
, vol.3
-
-
Altfeld, M.1
Kalife, E.T.2
Qi, Y.3
-
39
-
-
0033152036
-
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS
-
Hendel H., Caillat-Zucman S., Lebuanec H. et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999; 162:6942-6946.
-
(1999)
J Immunol
, vol.162
, pp. 6942-6946
-
-
Hendel, H.1
Caillat-Zucman, S.2
Lebuanec, H.3
-
40
-
-
16944366524
-
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
-
Goulder P.J., Phillips R.E., Colbert R.A. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997; 3:212-217.
-
(1997)
Nat Med
, vol.3
, pp. 212-217
-
-
Goulder, P.J.1
Phillips, R.E.2
Colbert, R.A.3
-
41
-
-
0034886611
-
Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines
-
Kaslow R.A., Rivers C., Tang J. et al. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J Virol 2001; 75:8681-8689.
-
(2001)
J Virol
, vol.75
, pp. 8681-8689
-
-
Kaslow, R.A.1
Rivers, C.2
Tang, J.3
-
42
-
-
63949087100
-
Adaptation of HIV-1 to human leukocyte antigen class I
-
Kawashima Y., Pfafferott K., Frater J. et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009; 458:641-645.
-
(2009)
Nature
, vol.458
, pp. 641-645
-
-
Kawashima, Y.1
Pfafferott, K.2
Frater, J.3
-
43
-
-
0037013083
-
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57
-
Gillespie G.M., Kaul R., Dong T. et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS 2002; 16:961-972.
-
(2002)
AIDS
, vol.16
, pp. 961-972
-
-
Gillespie, G.M.1
Kaul, R.2
Dong, T.3
-
44
-
-
0034105485
-
HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other
-
Goulder P.J., Tang Y., Pelton S.I., and Walker B.D. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other. J Virol 2000; 74:5291-5299.
-
(2000)
J Virol
, vol.74
, pp. 5291-5299
-
-
Goulder, P.J.1
Tang, Y.2
Pelton, S.I.3
Walker, B.D.4
-
45
-
-
0034646143
-
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
-
Migueles S.A., Sabbaghian M.S., Shupert W.L. et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 2000; 97:2709-2714.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 2709-2714
-
-
Migueles, S.A.1
Sabbaghian, M.S.2
Shupert, W.L.3
-
46
-
-
20144389058
-
Retroviral recombination in vivo: Viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef
-
Kim E.Y., Busch M., Abel K. et al. Retroviral recombination in vivo: viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef. J Virol 2005; 79:4886-4895.
-
(2005)
J Virol
, vol.79
, pp. 4886-4895
-
-
Kim, E.Y.1
Busch, M.2
Abel, K.3
|